[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
The Cutting Edge: Challenges in Medical and Surgical Therapies
February 2011February 21, 2011

Retiform Purpura and Digital Gangrene Secondary to Antiphospholipid Syndrome Successfully Treated With Sildenafil

Author Affiliations

Departments of Dermatology (Drs Gonzalez, Price, Kamino, and Schaffer), Pediatrics (Drs Kahn and Schaffer), and Pathology (Dr Kamino), New York University School of Medicine, New York; and Phoenix Children's Hospital, Phoenix, Arizona (Dr Price)

 

EDWARD W.COWENMD MHScMURADALAMMDWILLIAM D.AUGHENBAUGHMD

Arch Dermatol. 2011;147(2):164-167. doi:10.1001/archdermatol.2011.4

A 16-year-old African American female adolescent with a 2-year history of systemic lupus erythematosus (featuring a malar erythema, photosensitivity, arthritis, and anemia in the setting of high-titer antinuclear, anti–double-strand DNA, anti-Smith, and anti-Ro antibodies) and Raynaud phenomenon presented with persistently painful and dusky toes since wearing a new pair of boots 2 weeks previously. She also noted an increased frequency of Raynaud episodes. Her dose of nifedipine was increased (from 30 mg/d to 60 mg/d) because of the latter, and she continued her baseline regimen of prednisone (5 mg/d), mycophenolate mofetil (1500 mg, twice daily), hydroxychloroquine (400 mg/d), and indomethacin (75 mg, twice daily). Despite this, she experienced worsening pain and progressive necrosis of her toes and was hospitalized for evaluation and treatment of impending digital gangrene.

First Page Preview View Large
First page PDF preview
First page PDF preview
×